Our portfolio includes generic products, biosimilar products, licenses and technology transfers from central countries. In addition, we have developed innovative solutions which combine different active ingredients in a single tablet presented in user friendly packaging for ease of transportation and intake.
Ganciclovir 500 mg
Ganciclovir is indicated to treat cytomegalovirus retinitis in immunodepressed patients, including patients with AIDS. It is also indicated to prevent cytomegalovirus infection in transplanted patients who present a risk of infection caused by this virus.
More information about Ciganclor®
Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg
Lamivudine + Zidovudine + Nevirapine are indicated for the treatment of the HIV (human immunodeficiency virus) in adults and children of 12 years of age and older.
More information about Lazinevir®
Tenofovir 300 mg
Tenofovir is indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Leuzan®
Lamivudine 300 mg + Tenofovir 300 mg
Lamivudine + Tenofovir are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Mivuten®
Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
Emtricitabine + Tenofovir Alafenamide are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Previd®
Nevirapine 200 mg
Nevirapine is indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Protease®
Abacavir 600 mg + Lamivudine 300 mg
Abacavir + Lamivudine are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Selmivir®
Rifabutin 150 mg
Rifabutin is indicated for the profilaxis and treatment of infections caused by Mycobacterium Avium in HIV patients. It is also indicated for the treatment of multidrug resistant tuberculosis.
More information about Tambux®
Efavirenz 600 mg + Emtricitabine 200 mg + Tenofovir 300 mg
Efavirenz + Emtricitabine + Tenofovir are indicated for the treatment of the HIV (human immunodeficiency virus) in adults and children of 12 years of age and older.
More information about Trivenz®
Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
Dolutegravir + Emtricitabine + Tenofovir Alafenamide are indicated in combination with other antiretroviral drugs for the treatment of adults infected with the human immunodeficiency virus type 1 (HIV-1).
More information about Tri-Zevuvir®
Oseltamivir 75 mg
Oseltamivir is indicated for the treatment of influenza in adults and children when symptoms are characteristic and the virus is circulating in the population (post-exposure prevention in ≥ 1 year after contact with a diagnosed influenza case; exceptionally, seasonal prevention post-exposure prevention in < 1 year during a pandemic outbreak.
More information about Veltamir®
Darunavir 600 mg + Ritonavir 100 mg
Darunavir + Ritonavir are indicated for the treatment of HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Virontar®
Darunavir 800 mg + Ritonavir 100 mg
Darunavir + Ritonavir are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Virontar N®
Efavirenz 600 mg
Efavirenz is indicated for the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Virorrever®
Lamivudine 300 mg
Lamivudine is indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Vuclodir®
Lamivudine 150 mg + Zidovudine 300 mg
Lamivudine + Zidovudine are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Zetavudin®
Zidovudine 10mg/ml
Zidovudine is indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Zetrotax®
Dolutegravir 50 mg
Dolutegravir is indicated for the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Zevuvir®
Dolutegravir 50 mg / Lamivudine 300 mg + Abacavir 600 mg
Dolutegravir + Lamivudine + Abacavir are indicated for the treatment of the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Zevuvir ABC Pack®
Dolutegravir 50 mg / Lamivudine 300 mg
Dolutegravir + Lamivudine are indicated for the HIV (human immunodeficiency virus) infection in adults and children of 12 years of age and older.
More information about Zevuvir L Pack®
Bendamustine 25-100 mg
Bendamustine is indicated for the treatment of the chronic lymphocytic leukemia (CLL). It is also indicated to treat patients with indolent B-cell non-Hodking lymphoma.
More information about Bemux®
Capecitabina 500 mg
Capecitabine is indicated as an adjuvant treatment after surgery in patients with stage 3 colon cancer (stage 3 Duke's staging), metastatic colorectal cancer and first line treatment of advanced gastric cancer in combination with a regimen including platinum.
More information about Capecit®
Cabozantinib 40 - 60 mg
Cabozantinib is indicated for the treatment of patients with advanced Renal Cell Carcinoma (RCC) as first line treatment in combination with nivolumab. Monotherapy in 2nd Line in RCC.
More information about Cidebin®
Docetaxel 20-80 mg
Docetaxel is indicated for the treatment of operable breast cancer with or without lymph node involvement, lung cancer, prostate cancer, gastric adenocarcinoma, or head and neck cancer.
More information about Doxetal®
Paclitaxel 30-150 mg
Paclitaxel is indicated for ovarian cancer, breast cancer and lung cancer.
More information about Drifen®
Bortezomib 3,5 mg
Bortezomib is indicated for the treatment of the multiple myeloma and mantle cell lymphoma.
More information about Egidon®
Ondansetron 8 mg
Ondansetron is indicated to control nausea and vomiting caused by chemotherapy.
More information about Espasevit®
Dasatinib 50-100 mg
Dasatinib is indicated for the treatment of chronic myelogenous leukemia and Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL).
More information about Fontrax®
Gemcitabine 200-1000 mg
Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer, in combination with cisplatin. It is also indicated for the treatment of patients locally advanced or metastatic adenocarcinoma of the pancreas, and as first line treatment of patients with non-microcytic lung cancer.
More information about Gezt®
Axitinib 5 mg
Axitinib is indicated for the treatment of adult patients with advanced renal cell cancer after failure of a previous treatment with sunitinib or cytokine.
More information about Idarrux®
Pazopanib 200-400 mg
Pazopanib is indicated for renal cell cancer and soft tissue sarcoma.
More information about Inibco®
Trifluridine + Tipiracilo 15+6.14 mg - 20+8.19 mg
Trifluridine + Tipiracil are indicated for the treatment of colon cancer and gastric cancer.
More information about Limustac®
Ferric derisomaltose 500-1000 mg
Ferric derisomaltose is indicated for the treatment of the iron deficiency when iron oral preparations are not effective or cannot be used, or when the clinical need exists to administer iron fast. The diagnosis must be based on laboratory tests.
More information about Monofer®
Carboplatin 150-450 mg
Carboplatin is indicated for the treatment of the advanced epithelial ovarian cancer and small cell lung cancer, associated to other chemotherapy treatments.
More information about Omilipis®
Irinotecan 100 mg
Irinotecan is indicated for the treatment of colon cancer.
More information about Pipetecan®
Abiraterone 250 mg
Abiraterone is indicated for the treatment of prostate cancer.
More information about Rexinth®
Doxorubicin 10-50 mg
Doxorubicin is indicated for the treatment of breast cancer, lung cancer and ovarian cancer.
More information about Roxorin®
Carfilzomib 60 mg
Carfilzomib is indicated as a single agent for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
More information about Seutig®
Pemetrexed 500 mg
Pemetrexed is indicated for the treatment of malignant pleural mesothelioma and non-microcytic lung cancer.
More information about Trexam®
Palbociclib 75, 100 y 125 mg
Ydesib® is indicated for the treatment of metastatic or locally advanced breast cancer.
More information about Ydesib®
Oxaliplatin 50-100 mg
Oxaliplatin is indicated for the treatment of colon cancer.
More information about Xaliplat®
Imatinib 100-400 mg
Imatinib is indicated for the treatment of chronic myelogenous leukemia and acute Philadelphia positive (Ph+) lymphoblastic leukemia (ALL).
More information about Ziatir®
Bevacizumab 100 mg/4 ml - 400 mg/16 ml
Bevacizumab is indicated for the treatment of colon cancer, lung cancer and ovarian cancer.
More information about Zutrab®
Teneligliptin 20 mg
TTeneligliptin is indicated to improve the control of the glycemia in adult patients with type II diabetes, who had no adequate response to the treatment of diet and exercise, aggregation of biguanides, sulfonylureas or thiazolodinediones.
More information about Addenta®
Amlodipine 5-10 mg
Amlodipine is indicated for the treatment of arterial hypertension. The drug may be used alone or in combination with other antihypertensive agents.
More information about Amze®
Clopidogrel 75 mg
Clopidogrel is indicated for the treatment of atherosclerotic vascular disease.
More information about Antiplaq®
Rosuvastatin 10-20-40 mg
Rosuvastatin calcium is indicated, in conjunction with diet, to decrease the LDL cholesterol level, increase the HDL cholesterol level and decrease triglycerides.
More information about Bilip®
Valsartan 80-160 mg
Valsartan is indicated for the treatment of essential arterial hypertention and mild to moderate heart failure in combination with diuretic drugs.
More information about Hiperval®
Sacubitril + Valsartan 24+26 mg - 49+51 mg - 97+103 mg
Sacubitril + Valsartan are indicated to reduce the risk of cardiovascular death and hospitalization resulting from heart failure in patients with chronic heart failure and ejection fraction.
More information about Hiperval Plus®
Rivaroxaban 2.5, 10, 15, 20 mg
Rivaroxaban is indicated for: Prevention of cerebrovascular accident (CVA) and systemic embolism in patients with non-valvular atrial fibrillation. Treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and prevention of recurrent DVT and/or PE. DVT prophylaxis after hip or knee replacement surgery. Prevention in coronary artery disease and peripheral arterial disease.
More information about Quarxom®
Losartan 50-100 mg
Losartan is indicated for the treatment of essential essential arterial hypertention.
More information about Tacardia®
Losartan 50 mg + Hydrochlorothiazide 12,5 mg
Losartan + Hydrochlorothiazide are indicated for the treatment of arterial hypertension in patients for whom the combined treatment is recommended.
More information about Tacardia D®
Telmisartan 40-80 mg
TTelmisartan is indicated for the treatment of essential arterial hypertension.
More information about Telcardia®
Atorvastatin 10-20-40 mg
Atorvastatin is indicated as adjuvant treatment to diet to reduce the high level total cholesterol.
More information about Vastina®
Carvedilol 6,25-12,5-25 mg
Carvedilol is indicated for the treatment of mild to moderate arterial hypertension, stable angina pectoris and congestive heart failure.
More information about Vicardol®
Sitagliptina 25-50-100 mg
Sitagliptin is indicated to improve glycemic control in adult patients with type 2 diabetes mellitus.
More information about Zuciva®
Adalilumab 40 mg/0,4 ml
Adalimumab is indicated for the reduction of signs and symptoms, inducing a significant clinical response and even clinical remission, inhibiting the progression of structural damage and improving functional capacity in adult patients with moderately to severely active rheumatoid arthritis.
More information about Armixa®
Codein 30 mg + Paracetamol 500 mg
Codein + Paracetamol are indicated for the treatment of mild to moderate pain, when a treatment with an opiate is adequate and for which alternative treatments are inadequate.
More information about Dolofrix®
Codein 60 mg + Paracetamol 300 mg
Codein + Paracetamol are indicated for the treatment of mild to moderate pain, when a treatment with an opiate is adecuate and for which alternative treatments are inadequate.
More information about Dolofrix Forte®
Donepezil 5-10 mg
Donepezil is indicated for the treatment of mild to moderate Alzheimer-type dementia.
More information about Donepés®
Doxepin 3-6 mg
Doxepin is indicated for the short-term treatment of primary insomnia.
More information about Insolid®
Lurasidone 20-40-80 mg
Lurasidone is indicated for the treatment of bipolar depression 1 and schizophrenia.
More information about Kytzan®
Pregabalin 75-150 mg
Pregabalin is indicated for the treatment of neuropathic pain, generalized anxiety disorder and fibromialgia. This pharmaceutical product is gluten free. Suitable for celiacs.
More information about Mystika®
Lamotrigine 25-50-100 and 200 mg
Neurica belongs to a group called antiepileptics. It is used to treat two conditions: epilepsy and bipolar disorder.
More information about Neurica®
Memantine 10-20 mg
Memantine is indicated for the treatment of Alzheimer-type dementia in moderate and serious phases.
More information about Prilben®
Cerebrolysin 215,2 mg
Cerebrolysin is indicated for the treatment of organic, metabolic and neurodegenerative disorders of the brain, especially Alzheimer-type senile dementia, post apoplectic disorders, traumatic brain injury and post surgical trauma, contusion or brain concussion.
More information about Renacenz®
Olanzapine 5-10 mg
Olanzapine is indicated for the treatment of schizophrenia, mania or mixed episodes associated with the bipolar disorder.
More information about Revertrix®
Paroxetine 20 mg
Paroxetine is indicated for the treatment of major depressive disorder, obsessive compulsive disorder, panic disorder with or without agoraphobia, social anxiety disorder, generalized anxiety disorder and post traumatic stress disorder.
More information about Sostel®
Escitalopram 10-20 mg
Escitalopram is indicated for the treatment of major depressive disorder, panic disorders with or without agoraphobia, social phobia, generalized anxiety disorders and obsessive compulsive disorder.
More information about Talpram®
Thioctic acid 600 mg
Thioctic acid is indicated for the treatment of central and peripheral neuropathies, especially from diabetic ethiology.
More information about Tioneurol®
Levetiracetam 500-1000 mg
Levetiracetam is indicated for the treatment of epileptic seizures.
More information about Vecetam®
Zolpidem Hemitartrato 10 mg
Zolpidem is indicated for the treatment of short-term sleep disorders
More information about Zolodorm®
Fingolimod HCL 0.5 mg
Fingolimod is indicated for the treatment of patients with recurring forms of multiple sclerosis, to reduce the frequency of clinical exacerbations and delay the accumulation of physical disabilities.
More information about Dropton®
Cladribine 10 mg
Cladribine is indicated for the treatment of adult patients with very active recurring multiple sclerosis defined by clinical or image features.
More information about Eurit®
Teriflunomida 14 mg
Teriflunomide is indicated for the treatment of patients with recurring forms of multiple sclerosis.
More information about Tenomid®
Folic Acid 1 and 5 mg
Folic Acid is indicated for the prevention and treatment of megaloblastic anemia due to folic acid deficiency.
More information about Ácido Fólico Richmond®
Tofacitinib 5 mg
Tofacitinib is indicated for the treatment of mild to serious active rheumatoid arthritis.
More information about Intrart®
Ondansetron 8 mg
Ondansetron is indicated to control chemotherapy-related nausea and vomiting.
More information about Espasevit®
Heparin sodium 5000 UI/ml
Heparin sodium is indicated in anticoagulant therapy to prevent blod clots and thrombi.
More information about Heparina Sódica Richmond®
Lidocaine (hydrochloride) 2 g/100 ml
Lidocaine is indicated to prevent and control pain in procedures affecting the female or male urethra, for the topical treatment of urethritis and as anesthetic lubricant for endotracheal intubation (oral and nasal).
More information about Regiocaina®
Remifentanil 5 mg
Remifentanil is indicated as an analgesic agent to be used during the induction/maintenance of the general anesthesia under strict supervision. It is also indicated to provide anesthesia and sedation in patients of 18 years of age and older on assisted mechanical ventilation in intensive care units.
More information about Remiflo®
Teicoplanin 400 mg
Teicoplanin is indicated for the treatment of severe infections caused by gram positive bacteria, especially the ones caused by Staphylococos.
More information about Teicox®
Tigecycline 50 mg
Tigecycline is indicated for the treatment of infections caused by strains sensitive to the microorganisms occurring in various clinical pictures in patients of 18 years of age and older.
More information about Tizoxim®
Atracurium 50 mg
Atracurium is indicated as a coadjuvant to the general anesthesia or sedation in the intensive care unit, to relax the skeletal muscles and to facilitate the tracheal intubation and mechanical ventilation.
More information about Tracurix®
Bevacizumab 5 mg/0,2 ml
Yriviak is indicated for the treatment of adult patients with neovascular (exudative) age-related macular degeneration (AMD).
More information about Yriviak®
NOTICE The legal content included on this site was designed exclusively to meet the needs of the health-care professionals for the adequate use of the pharmaceutical products. It does not contain promotional information. All the texts referring to our prescription products are compliant with the guidelines approved by ANMAT, the Argentine administration for drugs, food and medical technology. Laboratorios Richmond always recommends consulting a qualified health-care professional if you have doubts regarding any given medical
I understand and wish to see the information